GO
Loading...

Pfizer Inc

More

  • April 18- Biogen Idec Inc is pricing its newly approved long-acting hemophilia drug, Alprolix, to cost U.S. patients, and insurers, about the same per year as older, less convenient therapies whose price can reach about $300,000 annually.

  • April 17- Teva Pharmaceutical Industries Ltd signed a deal that allows the Israeli drugmaker to launch a generic version of Pfizer Inc's blockbuster painkiller Celebrex in December. "helps them to get through 2014 with a lot less competition," Morningstar analyst Damien Conover said.

  • April 17- Teva Pharmaceutical Industries Ltd said it settled a patent lawsuit with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster painkiller Celebrex in December.

  • April 17- Teva Pharmaceutical Industries Ltd said it settled a patent litigation with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster pain medication, Celebrex, in December. Celebrex's basic chemical patent expires on May 30.

  • Final Glance: Pharmaceuticals companies Wednesday, 16 Apr 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 09 or. 1 percent, to $73.45. Bristol-Myers Squibb Co. rose$. 94 or 2.0 percent, to $49.11. Hospira fell$. 43 or 1.0 percent, to $43.00.

  • Midday Glance: Pharmaceuticals companies Wednesday, 16 Apr 2014 | 1:30 PM ET

    Baxter International Inc. fell$. 04 or. 1 percent, to $73.32. Bristol-Myers Squibb Co. rose $1.00 or 2.1 percent, to $49.17. Hospira fell$. 52 or 1.2 percent, to $42.91.

  • Most active New York Stock Exchange-traded stocks Wednesday, 16 Apr 2014 | 1:30 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. rose 1.2 percent to $36.10 with 23,832,000 shares traded. Alcoa Inc. rose 2.8 percent to $13.42 with 36,770,000 shares traded.

  • Early Glance: Pharmaceuticals companies Wednesday, 16 Apr 2014 | 10:27 AM ET

    Baxter International Inc. rose$. 51 or. 7 percent, to $73.87. Bristol-Myers Squibb Co. rose$. 40 or. 8 percent, to $48.57. Hospira fell$. 24 or. 6 percent, to $43.19.

  • Final Glance: Pharmaceuticals companies Monday, 14 Apr 2014 | 6:01 PM ET

    Baxter International Inc. rose$. 78 or 1.1 percent, to $72.76. Bristol-Myers Squibb Co. fell$. 87 or 1.8 percent, to $47.96. Hospira rose$. 79 or 1.9 percent, to $42.93.

  • Most active New York Stock Exchange-traded stocks Monday, 14 Apr 2014 | 2:08 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Advanced Micro Devices Inc. rose 1.6 percent to $3.71 with 22,506,600 shares traded. Alcoa Inc. rose 2.6 percent to $12.86 with 29,500,100 shares traded.

  • Midday Glance: Pharmaceuticals companies Monday, 14 Apr 2014 | 2:08 PM ET

    Baxter International Inc. rose$. 79 or 1.1 percent, to $72.77. Bristol-Myers Squibb Co. fell$. 39 or. 8 percent, to $48.44. Hospira rose $1.35 or 3.2 percent, to $43.49.

  • Early Glance: Pharmaceuticals companies Monday, 14 Apr 2014 | 10:21 AM ET

    Baxter International Inc. rose$. 47 or. 7 percent, to $72.45. Bristol-Myers Squibb Co. fell$. 07 or. 1 percent, to $48.77. Hospira rose$. 10 or. 2 percent, to $42.24.

  • Final Glance: Pharmaceuticals companies Friday, 11 Apr 2014 | 6:03 PM ET

    Baxter International Inc. fell$. 28 or. 4 percent, to $71.98. Bristol-Myers Squibb Co. fell$. 46 or. 9 percent, to $48.83. Hospira fell$. 58 or 1.4 percent, to $42.14.

  • Midday Glance: Pharmaceuticals companies Friday, 11 Apr 2014 | 1:51 PM ET

    Baxter International Inc. rose$. 15 or. 2 percent, to $72.41. Bristol-Myers Squibb Co. rose$. 07 or. 1 percent, to $49.36. Hospira fell$. 26 or. 6 percent, to $42.46.

  • Most active New York Stock Exchange-traded stocks Friday, 11 Apr 2014 | 1:51 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. rose. 2 percent to $35.20 with 34,303,500 shares traded. Alcoa Inc. fell 1.3 percent to $12.54 with 44,879,300 shares traded.

  • April 10- Phibro Animal Health Corp's initial public offering was priced at $15 per share, an underwriter said, below its expected price range of $16- $18 per share. Backed by UK private equity firm 3 i Group Plc, Teaneck, New Jersey- based Phibro is selling 7.352 million shares in the offering.

  • WASHINGTON, April 10- The leading U.S. pharmaceutical industry trade group on Thursday defended the cost of Gilead Sciences Inc's new hepatitis C drug, Sovaldi, saying such treatments offer a priceless breakthrough for patients with the liver-destroying virus.

  • Adamas Pharma wavers after IPO raises $48 million Thursday, 10 Apr 2014 | 11:09 AM ET

    NEW YORK— Shares of Adamas Pharmaceuticals wavered Thursday after the drug developer's initial public offering raised $48 million. The offering of 3 million shares priced at $16 each, the low end of an expected range of $16 to $18. The stock rose as much as $1.24, or 7.8 percent, in morning trading but later declined 25 cents to $15.75.

  • Early Glance: Pharmaceuticals companies Thursday, 10 Apr 2014 | 10:24 AM ET

    Baxter International Inc. fell$. 37 or. 5 percent, to $73.08. Bristol-Myers Squibb Co. fell$. 45 or. 9 percent, to $50.12. Hospira fell$. 56 or 1.3 percent, to $43.65.

  • Final Glance: Pharmaceuticals companies Wednesday, 9 Apr 2014 | 6:06 PM ET

    Baxter International Inc. rose $1.15 or 1.6 percent, to $73.45. Bristol-Myers Squibb Co. rose $1.51 or 3.1 percent, to $50.57. Hospira rose$. 69 or 1.6 percent, to $44.21.

Most Popular Video

Monday, 14 Apr 2014 | 11:43 AM ET

Dr. Steven Horng, Beth Israel Deaconess Medical Center, explains how Google Glass provided crucial support in an emergency situation and helped save a life.

Tuesday, 15 Apr 2014 | 11:36 PM ET

John Sculley, former Apple CEO and Managing Partner at Inflexionpoint, expects Alibaba to push on with its buying spree after listing in the U.S.

Thursday, 17 Apr 2014 | 4:00 PM ET

On this week's "$ave Me," CNBC's Kelli Grant gives tips on how to finally earn enough for that free airline award seat.